Skip to main content
SpringerLink
Log in

Neurogenic bladder and chronic urinary retention associated with MDMA abuse

  • Toxicology Observations
  • Published:
Journal of Medical Toxicology Aims and scope Submit manuscript

Abstract

Introduction

The use of 3,4-methylenedioxymethamphetamine (MDMA, known as “ecstasy”), a synthetic amphetamine and “club drug,” has been associated with acute, transient urinary retention. We report a case of neurogenic bladder and chronic urinary retention associated with MDMA abuse.

Case report

A 21-year-old male presented to the emergency department (ED) because he had abdominal pain and difficulty urinating. He had experienced difficulty in initiating urination over the past 1.5 months, with periods of 24 to 36 hours between voids and large volumes of urine. The patient had a chronic pattern of MDMA use, taking 4 tablets/day for 3 months. Two weeks before coming to the ED, he had been admitted to an inpatient drug rehabilitation center. During the time since that admission, the patient had visited EDs repeatedly for insertion and removal of Foley catheters to relieve the urinary retention until he could be admitted to a urologic service. Cystometrogram was abnormal, finding no sensation of bladder fullness after instillation of 350 mL of saline and inability to generate a voluntary voiding pressure. Cystoscopy revealed no outlet obstruction. The findings were consistent with neurogenic bladder. The patient was given prescriptions for bethanecol and phenazopyridine, and told to continue a 10-day course of sulfamethoxazole/trimethoprim for urinary tract infection. He was discharged with a Foley catheter in place. Symptoms of urinary retention persisted at 1-year follow-up, despite self-catheterization and complete cessation of MDMA use.

Conclusion

Chronic MDMA use may lead to neurogenic bladder and chronic urinary retention.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Grinspoon L, Bakalar JB. Can drugs be used to enhance the psychotherapeutic process?Am J Psychother 1986;40:393–404.

    PubMed  CAS  Google Scholar 

  2. Greer G, Tolbert R. Subjective reports of the effects of MDMA in a clinical setting.J Psychoactive Drugs 1986;18:319–327.

    PubMed  CAS  Google Scholar 

  3. Doblin R. A clinical plan for MDMA (Ecstasy) in the treatment of posttraumatic stress disorder (PTSD): partnering with the FDA.J Psychoactive Drugs 2002;34185-34194.

  4. National Survey on Drug Use and Health,2003. Substance Abuse and Mental Health Services Administration (SAMHSA), U.S. Department of Health and Human Services.

  5. Delgado JH, Caruso MJ, Waksman JC, Honigman B, Stillman D. Acute, transient urinary retention from combined ecstasy and methamphetamine use.J Emerg Med 2004;26:173–175.

    Article  PubMed  Google Scholar 

  6. Inman DS, Greene D. The agony and the ecstacy: acute urinary retention after MDMA abuse.BJU Int 2003;91:123.

    Article  PubMed  CAS  Google Scholar 

  7. Bryden AA, Rothwell PJ, O’Reilly PH. Urinary retention with misuse of “ecstasy.”BMJ 1995;310:504.

    PubMed  CAS  Google Scholar 

  8. Gee P, Richardson S, Woltersdorf W, Moore G. Toxic effects of BZP-based herbal party pills in humans: a prospective study in Christchurch, New Zealand.N Z Med J 2005;118(1227:U1784.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Emergency Medicine, University of Maryland School of Medicine, 110 South Paca Street, 6th Floor, Suite 200, 21201, Baltimore, MD

    John R. Beuerle & Fermin Barrueto

  2. Department of Emergency Medicine, George Washington University, Washington, DC

    Fermin Barrueto

Authors
  1. John R. Beuerle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Fermin Barrueto
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Fermin Barrueto.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Beuerle, J.R., Barrueto, F. Neurogenic bladder and chronic urinary retention associated with MDMA abuse. J. Med. Toxicol. 4, 106–108 (2008). https://doi.org/10.1007/BF03160964

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03160964

Keywords

Search

Navigation